Question

I am a breastfeeding mother and i want to know if it is safe to use BRN 5759131? Is BRN 5759131 safe for nursing mother and child? Does BRN 5759131 extracts into breast milk? Does BRN 5759131 has any long term or short term side effects on infants? Can BRN 5759131 influence milk supply or can BRN 5759131 decrease milk supply in lactating mothers?

Answer by DrLact: About BRN 5759131 usage in lactation

No information is available on the use of BRN 5759131 during breastfeeding. The manufacturer recommends that women not breastfeed during treatment and for 2 weeks following the final dose of BRN 5759131. However, because BRN 5759131 is used with doxorubicin, the abstinence period might be longer, depending on the doxorubicin dose.

Alternate Drugs

Alemtuzumab(Low Risk)
Vinorelbine(Dangerous)
Vincristine(Dangerous)
Rituximab(Low Risk)
Dacarbazine(Dangerous)
Tamoxifen(Dangerous)
Cladribine(Dangerous)
Bevacizumab(Low Risk)
Mitoxantrone(Dangerous)
Letrozole(Dangerous)
Thioguanine(Dangerous)
Docetaxel(Dangerous)
Dasatinib(Unsafe)
Exemestane(Dangerous)
Pazopanib(Unsafe)
Hydroxyurea(Low Risk)
Nilotinib(Unsafe)
Trastuzumab(Unsafe)
Gemcitabine(Dangerous)
Etoposide(Dangerous)
Doxorubicin(Dangerous)
Dactinomycin(Dangerous)
Cyclophosphamide(Dangerous)
Imatinib(Unsafe)
Ipilimumab(Unsafe)
Cisplatin(Unsafe)
Cetuximab(Unsafe)
Busulfan(Dangerous)
Carboplatin(Dangerous)
Nivolumab(Unsafe)
Erlotinib(Unsafe)
Paclitaxel(Dangerous)
Vinblastine(Dangerous)
Fluorouracil(Dangerous)
Bleomycin(Dangerous)
Orlistat(Low Risk)
Dasatinib(Unsafe)
Pazopanib(Unsafe)
Nilotinib(Unsafe)
Gemcitabine(Dangerous)
Imatinib(Unsafe)
Erlotinib(Unsafe)
Doxorubicin(Dangerous)
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.